Page last updated: 2024-10-26

valproic acid and Anosmia

valproic acid has been researched along with Anosmia in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Anosmia: Complete or severe loss of the subjective sense of smell. Loss of smell may be caused by many factors such as a cold, allergy, OLFACTORY NERVE DISEASES, viral RESPIRATORY TRACT INFECTIONS (e.g., COVID-19), aging and various neurological disorders (e.g., ALZHEIMER DISEASE).

Research Excerpts

ExcerptRelevanceReference
"Valproic acid (VPA) has been widely used for the treatment of epilepsy."3.30Therapeutic Potential of Valproic Acid for Postviral Olfactory Dysfunction: A Single-Arm Pilot Study. ( Hira, D; Kikuoka, H; Matsumoto, K; Ogawa, T; Shimizu, T; Tojima, I, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ogawa, T1
Matsumoto, K1
Tojima, I1
Kikuoka, H1
Hira, D1
Shimizu, T1

Trials

1 trial available for valproic acid and Anosmia

ArticleYear
Therapeutic Potential of Valproic Acid for Postviral Olfactory Dysfunction: A Single-Arm Pilot Study.
    The Annals of otology, rhinology, and laryngology, 2023, Volume: 132, Issue:6

    Topics: Animals; Anosmia; Olfaction Disorders; Pilot Projects; Smell; Valproic Acid

2023